Protagenic Therapeutics Inc (PTIX)

May 13, 2025

Protagenic Therapeutics, Inc.\new SEC 10-Q Report - TradingView

May 13, 2025

May 01, 2025

Protagenic Therapeutics Inc (PTIX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com

May 01, 2025

Apr 29, 2025

Protagenic Therapeutics Announces Reverse Stock Split - TipRanks

Apr 29, 2025

Apr 29, 2025

Protagenic Therapeutics announces 1-for-14 reverse stock split - Investing.com

Apr 29, 2025

Apr 29, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 29, 2025

Apr 29, 2025

Protagenic Takes Bold Step: 1-for-14 Reverse Split Aims to Preserve Nasdaq Listing - Stock Titan

Apr 29, 2025

Apr 29, 2025

Protagenic Therapeutics to Effect 1-for-14 Reverse Stock Split - The Globe and Mail

Apr 29, 2025

Apr 28, 2025

Stock Surge: Protagenic Therapeutics Inc (PTIX) Closes at 0.23, Marking a -9.20 Increase/Decrease - DWinneX

Apr 28, 2025

Apr 26, 2025

Protagenic Therapeutics to Present at the B. Riley Securities Neuro and Ophthalmology Virtual Investor Conference on April 27th - ACCESS Newswire

Apr 26, 2025

Apr 24, 2025

Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.28, a 0.69 Surge/Decline - DWinneX

Apr 24, 2025

Apr 22, 2025

PTIX stock touches 52-week low at $0.25 amid sharp annual decline - MSN

Apr 22, 2025

Apr 19, 2025

Protagenic Therapeutics stockholders approve reverse split authority - Investing.com Australia

Apr 19, 2025

Apr 18, 2025

Protagenic Therapeutics stockholders approve reverse split authority By Investing.com - Investing.com South Africa

Apr 18, 2025

Apr 08, 2025

What Did We Note About Insider Trading At Protagenic Therapeutics Inc (NASDAQ: PTIX)? - stocksregister.com

Apr 08, 2025

Apr 03, 2025

Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 03, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Apr 02, 2025

Mar 31, 2025

Protagenic Therapeutics, Inc.\new SEC 10-K Report - TradingView

Mar 31, 2025

Mar 28, 2025

PTIX stock plunges to 52-week low, hitting $0.23 - Investing.com India

Mar 28, 2025

Mar 28, 2025

PTIX stock plunges to 52-week low, hitting $0.23 By Investing.com - Investing.com Australia

Mar 28, 2025

Mar 25, 2025

Protagenic Therapeutics (NASDAQ:PTIX) Stock Price Down 6.5% – Here’s Why - Defense World

Mar 25, 2025

Mar 04, 2025

BDSX Shrinks Loss With Revenue Growth, ALLR Plans $5Mln Share Buyback, What's The Buzz At PTIX? - RTTNews

Mar 04, 2025

Feb 25, 2025

PTIX stock plunges to 52-week low, hitting $0.25 By Investing.com - Investing.com Canada

Feb 25, 2025

Feb 24, 2025

Protagenic Therapeutics adjusts stock option prices By Investing.com - Investing.com South Africa

Feb 24, 2025

Feb 24, 2025

Protagenic Therapeutics adjusts stock option prices - Investing.com India

Feb 24, 2025

Feb 24, 2025

Protagenic Therapeutics Reprices Stock Options at Annual Meeting - TipRanks

Feb 24, 2025

Feb 06, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Feb 06, 2025

Feb 06, 2025

PTIX’s Market Whiplash: -23.55% YTD Decline, -25.97% Plunge in 30 Days - The InvestChronicle

Feb 06, 2025

Feb 06, 2025

Stock Market Recap: Protagenic Therapeutics Inc (PTIX) Concludes at 0.37, a 11.82 Surge/Decline - The Dwinnex

Feb 06, 2025

Feb 06, 2025

Why Coherent Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga

Feb 06, 2025

Feb 05, 2025

Protagenic Therapeutics Inc (PTIX) Shares Plummet Below 1-Year High - The News Heater

Feb 05, 2025

Feb 02, 2025

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Sees Significant Decrease in Short Interest - Defense World

Feb 02, 2025

Jan 28, 2025

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice - ACCESS Newswire

Jan 28, 2025

Jan 25, 2025

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results - ACCESS Newswire

Jan 25, 2025

Jan 24, 2025

Protagenic Therapeutics Announces Date of Annual Shareholder Meeting - ACCESS Newswire

Jan 24, 2025

Jan 24, 2025

Protagenic Therapeutics Announces Closing of Private Placement for Aggregate Gross Proceeds of $1.275 Million - ACCESS Newswire

Jan 24, 2025

Jan 21, 2025

Protagenic Therapeutics to Effect 1-for-4 Reverse Stock Split - ACCESS Newswire

Jan 21, 2025

Jan 15, 2025

Performance Tech Stock Hits 52-Week Low at $0.44 Amid Market Challenges - Investing.com

Jan 15, 2025

Jan 13, 2025

Protagenic Therapeutics, Inc. Enters into Amendment No. 1 to At Market Issuance Sales Agreement - Defense World

Jan 13, 2025

Jan 11, 2025

Protagenic Therapeutics Inc’s (PTIX) -12.44% Retreat Justifies A Second Look - Stocks Register

Jan 11, 2025

Dec 25, 2024

PTIX stock touches 52-week low at $0.45 amid market challenges - Investing.com Nigeria

Dec 25, 2024

Dec 16, 2024

Pre-market Movers: EWTX, TNXP, LNSR, VRDN... - RTTNews

Dec 16, 2024

Dec 05, 2024

Protagenic Therapeutics (NASDAQ:PTIX) Faces Delisting Threat from NasdaqUnited States Securities and Exchange CommissionWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934D - Defense World

Dec 05, 2024

Dec 03, 2024

Protagenic Therapeutics faces Nasdaq delisting over equity deficit - Investing.com

Dec 03, 2024

Dec 02, 2024

PTIX stock touches 52-week low at $0.48 amid market challenges - Investing.com India

Dec 02, 2024

Nov 27, 2024

Galapagos NV (GLPG) Stock Surges Amid Strong Industry Performanc - GuruFocus.com

Nov 27, 2024

Nov 25, 2024

Protagenic Therapeutics Receives Delist Determination Letter from Nasdaq - Defense World

Nov 25, 2024

Nov 23, 2024

Protagenic Therapeutics faces Nasdaq delisting over equity shortfall - Investing.com India

Nov 23, 2024

Nov 23, 2024

Protagenic Therapeutics faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia

Nov 23, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Protagenic Therapeu - GuruFocus.com

Nov 15, 2024